在经过计算设计的微型蛋白质中,除化和异构化到难以捉摸的异酸盐
Katerina M Blejec1, Colin A Smith1
1Department of Chemistry, Wesleyan University, Middletown, Connecticut, USA.
Protein science : a publication of the Protein Society
|February 22, 2026
概括
计算式蛋白质设计为治疗创造了新的微型蛋白质. 研究人员使用核磁共振来研究除化,发现异酸盐产物在动力学上受到青,影响小蛋白稳定性和治疗潜力.
科学领域:
- 生物化学 生物化学
- 计算生物学 计算生物学
- 结构生物学 结构生物学
背景情况:
- 新生微蛋白通过结合特定蛋白质位点提供治疗潜力.
- 超稳定的迷你蛋白质可以经历自发的除化,影响它们的功能.
- 阿斯巴拉金被除化成阿斯巴达酸和异阿斯巴达酸可以改变蛋白质的结构和稳定性.
研究的目的:
- 在实时模型小蛋白 (EHEE_rd2_0005) 中特征阿斯巴拉金脱化动力学.
- 阐明阿斯巴酸盐和异阿斯巴酸盐产品之间的结构和稳定性差异.
- 调查异酸盐形成的动力与热力学优势.
主要方法:
- 使用未标记的1D蛋白质核磁共振 (NMR) 进行实时运动分析.
- 采用2DNMR实验来验证1DNMR发现,并描述除化产品的特征.
- 应用计算方法来补充实验数据.
主要成果:
- 鉴定和描述了从阿斯巴拉金脱中形成的阿斯巴拉酸盐和异阿斯巴拉酸盐产物.
- 观察到异酸盐产品诱导的结构变化比酸盐更大,显著降低了热稳定性.
- 发现异酸盐的形成在动力学上比热力学上更受青,导致初始度过时高.
结论:
- 核磁共振是一种强大的技术,用于识别和表征蛋白质异构体,包括异酸盐.
- 异酸盐形成的动力优势对小蛋白质的稳定性构成了挑战.
- 预防或减轻脱阿米达的策略对于开发微型蛋白质作为有效的治疗方法至关重要.
相关概念视频
Amino Acid Catabolism
1.4K
Microorganisms rely on proteins as an essential carbon and energy source, particularly in environments with limited polysaccharides or lipids. However, proteins are too large to cross the plasma membrane unaided, necessitating enzymatic degradation. Microbes secrete extracellular proteases and peptidases that hydrolyze proteins into peptides, which can then be transported across the membrane. Once inside the cell, intracellular proteases degrade these peptides into free amino acids, which...
1.4K
Protein Folding
11.8K
Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
11.8K
Protein Folding
128.7K
Overview
128.7K
Protein Modifications in the RER
7.3K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
7.3K
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
The Proteasome
1.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.8K


